(Q42634677)

4 November 2017

Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections (English)

1 reference

4 November 2017

A M Tammewar

1

1 reference

4 November 2017

L Cheng

2

1 reference

4 November 2017

O R Kayikcioglu

3

1 reference

4 November 2017

I A Falkenstein

4

1 reference

4 November 2017

I Kozak

5

1 reference

4 November 2017

M H Goldbaum

6

1 reference

4 November 2017

W R Freeman

7

1 reference

4 November 2017

language of work or name

English

0 references

publication date

17 April 2008

1 reference

British Journal of Ophthalmology

4 November 2017

1 reference

4 November 2017

92

1 reference

4 November 2017

6

1 reference

4 November 2017

810-813

1 reference

Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.

4 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Ocular morbidity associated with intravitreal triamcinolone acetonide

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intraocular pressure alterations following intravitreal triamcinolone acetonide

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

The effect of intravitreal triamcinolone acetonide on intraocular pressure

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal injection of triamcinolone for diffuse diabetic macular edema

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intraocular pressure after intravitreal injection of triamcinolone acetonide

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal triamcinolone for refractory diabetic macular edema

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Complications of intravitreal injection of triamcinolone acetonide

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Safety of intravitreal high-dose reinjections of triamcinolone acetonide

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal triamcinolone acetonide and intraocular pressure

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intraocular availability of triamcinolone acetonide after intravitreal injection

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776725

Intravitreal triamcinolone and elevated intraocular pressure

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18420748

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18420748

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18420748

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BJO.2007.126227

1 reference

4 November 2017

1 reference

4 November 2017

PubMed publication ID

18420748

1 reference